Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival and neurological outcome after bystander versus lay responder defibrillation in out-of-hospital cardiac arrest: A sub-study of the BOX trial.
Sarkisian L, Isse YA, Gerke O, Obling LER, Paulin Beske R, Grand J, Schmidt H, Højgaard HF, Meyer MAS, Borregaard B, Hassager C, Kjaergaard J, Møller JE. Sarkisian L, et al. Among authors: schmidt h. Resuscitation. 2024 Feb;195:110059. doi: 10.1016/j.resuscitation.2023.110059. Epub 2023 Nov 25. Resuscitation. 2024. PMID: 38013147 Free article.
Comparison of mortality in patients with acute myocardial infarction accidentally admitted to non-cardiology departments versus that in patients admitted to coronary care units.
D'Souza M, Saaby L, Poulsen TS, Diederichsen AC, Hosbond S, Diederichsen SZ, Larsen TB, Schmidt H, Gerke O, Hallas J, Gislason G, Thygesen K, Mickley H. D'Souza M, et al. Among authors: schmidt h. Am J Cardiol. 2014 Oct 15;114(8):1151-7. doi: 10.1016/j.amjcard.2014.07.035. Epub 2014 Jul 30. Am J Cardiol. 2014. PMID: 25169985
Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.
Wiberg S, Hassager C, Schmidt H, Thomsen JH, Frydland M, Lindholm MG, Høfsten DE, Engstrøm T, Køber L, Møller JE, Kjaergaard J. Wiberg S, et al. Among authors: schmidt h. Circulation. 2016 Dec 20;134(25):2115-2124. doi: 10.1161/CIRCULATIONAHA.116.024088. Epub 2016 Nov 12. Circulation. 2016. PMID: 27838646 Clinical Trial.
The Glucagon-Like Peptide-1 Analog Exenatide Increases Blood Glucose Clearance, Lactate Clearance, and Heart Rate in Comatose Patients After Out-of-Hospital Cardiac Arrest.
Wiberg S, Kjaergaard J, Schmidt H, Thomsen JH, Frydland M, Winther-Jensen M, Lindholm MG, Høfsten DE, Engstrøm T, Køber L, Møller JE, Hassager C. Wiberg S, et al. Among authors: schmidt h. Crit Care Med. 2018 Feb;46(2):e118-e125. doi: 10.1097/CCM.0000000000002814. Crit Care Med. 2018. PMID: 29189347 Clinical Trial.
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.
Udesen NJ, Møller JE, Lindholm MG, Eiskjær H, Schäfer A, Werner N, Holmvang L, Terkelsen CJ, Jensen LO, Junker A, Schmidt H, Wachtell K, Thiele H, Engstrøm T, Hassager C; DanGer Shock investigators. Udesen NJ, et al. Among authors: schmidt h. Am Heart J. 2019 Aug;214:60-68. doi: 10.1016/j.ahj.2019.04.019. Epub 2019 May 6. Am Heart J. 2019. PMID: 31176289 Free article. Clinical Trial.
Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study.
Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Sørensen A, Frydland M, Lassen AT, Udesen NLJ, Schmidt H, Ravn HB, Møller JE. Helgestad OKL, et al. Among authors: schmidt h. Eur J Heart Fail. 2019 Nov;21(11):1370-1378. doi: 10.1002/ejhf.1566. Epub 2019 Jul 24. Eur J Heart Fail. 2019. PMID: 31339222 Free article.
6,342 results